TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AARD

Aardvark Therapeutics, Inc.

Healthcare · Biotechnology

5.10$ -8.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AARD
Line item 2022 2023 2024 2025
– -37.1% +635.6% +51.2%
– -37.1% +615.1% +50.9%
– -37.4% +533.2% -23.7%
– -38.0% +637.4% +49.4%
– +1.5% +191.5% -92.0%
– +132.3% +256.5% +114.1%
– +12.0% +201.8% +30.5%
– +299.6% +122.0% -9.8%
– – – –
– – – –
– +0.0% +1.5% +0.6%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?